A. D. Beadell Investment Counsel Inc. Sells 1,225 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

A. D. Beadell Investment Counsel Inc. decreased its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating) by 8.7% during the second quarter, Holdings Channel.com reports. The fund owned 12,875 shares of the pharmacy operator’s stock after selling 1,225 shares during the quarter. A. D. Beadell Investment Counsel Inc.’s holdings in Walgreens Boots Alliance were worth $487,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in WBA. Rise Advisors LLC bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth $27,000. Iron Horse Wealth Management LLC raised its holdings in Walgreens Boots Alliance by 56.0% in the first quarter. Iron Horse Wealth Management LLC now owns 635 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 228 shares in the last quarter. GoalVest Advisory LLC grew its stake in shares of Walgreens Boots Alliance by 10,828.6% during the second quarter. GoalVest Advisory LLC now owns 765 shares of the pharmacy operator’s stock worth $29,000 after acquiring an additional 758 shares during the last quarter. City State Bank purchased a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth about $30,000. Finally, Tompkins Financial Corp boosted its position in Walgreens Boots Alliance by 215.7% in the first quarter. Tompkins Financial Corp now owns 947 shares of the pharmacy operator’s stock valued at $42,000 after buying an additional 647 shares during the last quarter. 57.33% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Price Performance

Shares of WBA traded down $0.64 during trading hours on Friday, hitting $32.68. 122,949 shares of the company were exchanged, compared to its average volume of 7,184,637. The company has a market capitalization of $28.24 billion, a PE ratio of 5.31, a PEG ratio of 1.44 and a beta of 0.62. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.78 and a quick ratio of 0.43. The firm has a fifty day simple moving average of $37.44 and a 200-day simple moving average of $41.31. Walgreens Boots Alliance, Inc. has a one year low of $32.92 and a one year high of $55.00.

Walgreens Boots Alliance (NASDAQ:WBAGet Rating) last released its earnings results on Thursday, June 30th. The pharmacy operator reported $0.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.95 by $0.01. The company had revenue of $32.60 billion during the quarter, compared to analyst estimates of $32.23 billion. Walgreens Boots Alliance had a return on equity of 16.20% and a net margin of 4.00%. The company’s revenue for the quarter was down 4.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.51 earnings per share. As a group, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 5.02 earnings per share for the current year.

Walgreens Boots Alliance Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 9th. Stockholders of record on Friday, August 19th were issued a $0.48 dividend. The ex-dividend date was Thursday, August 18th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 5.88%. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.48. Walgreens Boots Alliance’s dividend payout ratio is presently 30.97%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on WBA shares. Cowen reduced their price objective on Walgreens Boots Alliance to $49.00 in a research note on Thursday, June 9th. Truist Financial reduced their price target on Walgreens Boots Alliance from $50.00 to $42.00 and set a “hold” rating on the stock in a research report on Friday, July 1st. Credit Suisse Group reduced their price target on Walgreens Boots Alliance from $52.00 to $43.00 and set a “neutral” rating on the stock in a research report on Friday, July 1st. StockNews.com raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a research report on Friday, August 19th. Finally, Royal Bank of Canada dropped their price target on Walgreens Boots Alliance from $46.00 to $42.00 and set a “sector perform” rating on the stock in a research note on Tuesday, July 5th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $45.75.

About Walgreens Boots Alliance

(Get Rating)

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Featured Articles

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.